2,847,381 Equity Shares of Entero Healthcare Solutions Limited are subject to a Lock-Up Agreement Ending on 14-MAY-2024. These Equity Shares will be under lockup for 91 days starting from 13-FEB-2024 to 14-MAY-2024.

Details:
Pursuant to Regulations 14 and 16 of the SEBI ICDR Regulations, an aggregate of 20% of the fully diluted postOffer Equity Share capital of our Company held by our Promoters (assuming full conversion of the vested options, if any, under the ESOP Scheme and full proposed conversion of the CCPS into Equity Shares), except for the Equity Shares offered by Prabhat Agrawal, Prem Sethi and OrbiMed Asia III Mauritius Limited pursuant to the Offer for Sale, shall be considered as minimum promoter?s contribution and locked-in for a period of eighteen (18) months from the date of Allotment (?Promoter?s Contribution?). Our Promoters? shareholding in excess of 20% of the fully diluted post-Offer Equity Share capital shall be locked in for a period of six (6) months from the
Allotment. Our Company had further filed an exemption application with SEBI seeking relaxation under Regulation 300(1) of the SEBI ICDR Regulations for eligibility of Equity Shares arising from the conversion of
CCPS (that were fully paid and held by the Promoters for a continuous period of more than one year), for computation of minimum promoters' contribution in terms of Regulation 15 of the SEBI ICDR Regulations, to the extent there is a shortfall in meeting the minimum Promoters? contribution requirement.

In terms of Regulation 17 of the SEBI ICDR Regulations, the entire pre- Offer Equity Share capital of our Company, shall be locked in for a period of six months from the date of Allotment in the Offer.

50% of the Equity Shares Allotted to Anchor Investors under the Anchor Investor Portion will be locked-in for a period of 30 days from the date of Allotment, and the remaining 50% of Equity Shares Allotted to Anchor Investors under the Anchor Investor Portion will be locked-in for a period of 90 days from the date of Allotment.